Replies to post #18422 on Mymetics Corp (MYMX)

[bow-tie]

This is a very very BIG Statement coming from Stallergenes:

Second-generation Allergen Immunotherapy with COP-virosomes, based on Anergis Contiguous Overlapping Peptides (COP) linked to Mymetics virosomes, were tested by Stallergenes Greer in a therapeutic model of birch pollen allergy. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice.
COP-virosomes were the only synthetic therapy able to fully reverse asthma symptoms as well as lung inflammation (i.e. significant reduction in eosinophils in bronchial fluids)

Read more: http://www.digitaljournal.com/pr/4695726#ixzz6OAhzEhuV